Salient Observations from Clinical Profile and Long-Term Outcome of a Cohort of Patients with Ectopic Cushing’s Syndrome
Indian Journal of Endocrinology and Metabolism · 2025-07 · 29 (4) · 434-439
DOI: 10.4103/ijem.ijem_96_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Endocrinology and Metabolism, online erschienen am 26.08.2025. Verfasst von Durairaj Arjunan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Introduction
Ectopic adrenocorticotropic hormone (ACTH)/corticotropin-releasing hormone production by tumours causes 5–10% of Cushing’s syndrome cases. We present a 21-patient case series with ectopic Cushing’s syndrome (ECS) from a tertiary care institute in India.
Methods
Data were collected retrospectively for patients from 1984 to 2004 and prospectively thereafter till 2019. This included clinical signs, diagnostic tests, comorbidities, imaging, management, outcomes, and follow-up data.
Results
In this study of 21 patients (14 males, mean age 32.4 ± 14 years) diagnosed with ECS, the mean lag period between the symptom onset and diagnosis was 15.9 ± 11.9 months. Predominant symptoms were proximal muscle weakness (85.7%), menstrual irregularity (85.7% of females), hyperpigmentation (76.2%), weight gain (61.9%), and infections (23.8%). Key signs included cuticular atrophy (100%), easy bruising (95.2%), and striae (71.4%). Despite 33.3% losing weight, 61.3% gained. 71.4% of the patients experienced diabetes, and 90.5% had hypertension as their metabolic complications. All patients exhibited disrupted cortisol circadian rhythms. The mean cortisol level at 0800 h was 1220 ± 556.2 nmol/L, while at 2300 h, it was 1108.3 ± 491.7 nmol/L. The median 0800-hour ACTH was 139 pg/ml. 22.2% displayed a paradoxical increase in morning cortisol post-high-dose dexamethasone suppression test. Thymic carcinoid is as prevalent as bronchial carcinoid in ECS causation.
Conclusion
ECS is rare, but it is crucial to distinguish it from Cushing’s disease, as tumour removal is the preferred treatment. In Cushing’s syndrome evaluations, ECS should always be considered since no single test is definitive for its diagnosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Neuroradiology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Urology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Histopathology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Zitieren
APA
Arjunan, D., Jain, N., Shah, R., Ahuja, C. K., Mavuduru, R. S., Bora, G. S., Pal, R., Bhadada, S. K., Bhansali, A., Basher, R. K., Saikia, U. N., & Walia, R. (2025). Salient Observations from Clinical Profile and Long-Term Outcome of a Cohort of Patients with Ectopic Cushing’s Syndrome. Indian Journal of Endocrinology and Metabolism, 29(4), 434-439. https://doi.org/10.4103/ijem.ijem_96_25
Vancouver
Arjunan D, Jain N, Shah R, Ahuja CK, Mavuduru RS, Bora GS, et al. Salient Observations from Clinical Profile and Long-Term Outcome of a Cohort of Patients with Ectopic Cushing’s Syndrome. Indian Journal of Endocrinology and Metabolism. 2025;29(4):434-439. doi:10.4103/ijem.ijem_96_25
BibTeX
@article{Arjunan2025,
author = {Arjunan, Durairaj and Jain, Nimisha and Shah, Ravi and Ahuja, Chirag K and Mavuduru, Ravimohan S and Bora, Girdhar S and Pal, Rimesh and Bhadada, Sanjay K and Bhansali, Anil and Basher, Rajender K and Saikia, Uma N and Walia, Rama},
title = {Salient Observations from Clinical Profile and Long-Term Outcome of a Cohort of Patients with Ectopic Cushing’s Syndrome},
journal = {Indian Journal of Endocrinology and Metabolism},
year = {2025},
volume = {29},
number = {4},
pages = {434--439},
doi = {10.4103/ijem.ijem_96_25}
}
EUVIMED